⌘K

Home/Filings/4/0001209191-09-001254

4//SEC Filing

Anderson Stephen Charles 4

Accession 0001209191-09-001254

CIK 0000949858other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 7:05 PM ET

Size

5.9 KB

Accession

0001209191-09-001254

Insider Transaction Report

Form 4

Period: 2008-12-31

ONCOGENEX PHARMACEUTICALS, INC.OGXI

Anderson Stephen Charles

CFO and Secretary

Transactions

Award
stock option (right to buy)
2008-12-31+40,000→ 40,000 total
Exercise: $3.00From: 2008-12-31Exp: 2015-12-31→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]10,000 shares are exercisable on each of Dec. 31, 2009, 2010, 2011 and 2012.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ONCOGENEX PHARMACEUTICALS, INC.

CIK 0000949858

Entity typeother

Related Parties

1

filerCIK 0001442674

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 7:05 PM ET
Size: 5.9 KB

View on SEC.gov